# ğŸ©º National Diabetes Audit (2024â€“25) â€“ Type 2 Diabetes Analysis  

This project analyses data from the **National Diabetes Audit (NDA) 2024â€“25** to explore the quality of diabetes care across England. Focusing on patients with Type 2 diabetes, it examines prevalence, delivery of care processes, achievement of treatment targets, regional variation, and potential inequalities by age, sex, and ethnicity.   

The project demonstrates skills in **Python-based data analysis**, including cleaning real-world healthcare datasets, exploratory data analysis (EDA), and deriving actionable insights relevant to healthcare analytics.  

---

## ğŸ¯ Objectives  

- Clean and structure the NDA dataset (Type 2 and other registrations, care processes, and treatment targets).  
- Explore prevalence of Type 2 diabetes nationally and across Integrated Care Boards (ICBs).  
- Analyse delivery of the 8 NICE-recommended care processes and identify variation.  
- Assess achievement of 3 NICE treatment targets (HbA1c, blood pressure, statins).  
- Compare care process vs. treatment target performance across ICBs.  
- Explore equity in outcomes across age, sex, and ethnicity groups.  

---

## ğŸ› ï¸ Tools & Libraries  

- Python  
- Jupyter Notebooks  
- Pandas  
- Matplotlib/Seaborn 
- SQLite (via Python)  

---

## ğŸ“Š Key Insights  

- **Prevalence:** Type 2 diabetes prevalence varies widely across ICBs, with some managing substantially larger patient populations.  
- **Care Processes:** Delivery of all 8 care processes ranges from above 70% in the best-performing ICBs to just over 30% in the lowest.  
- **Treatment Targets:** HbA1c control is the hardest target to meet, with only 65% of patients reaching it, compared with 83% for blood pressure and 78% for statins. Only ~45% of patients achieve all 3 simultaneously.  
- **Regional Variation:** There is a consistent gap between the best- and worst-performing ICBs, suggesting systematic differences in service delivery.  
- **Equity:** Differences are mainly in **who has diabetes** (prevalence by age, sex, ethnicity) rather than in **care quality once diagnosed**. Outcomes are broadly similar across groups, though younger adults and minority groups remain important to monitor.  

---

## ğŸ“‚ Project Structure  
```
nda-2024-25-eda/
â”œâ”€â”€ nda_2024_2025_eda.ipynb # Jupyter notebook with full cleaning, analysis, and insights
â””â”€â”€ README.md # Project summary and documentation
```

---

## ğŸ“Œ Status  

âœ… Completed  

---

## ğŸš€ Next Steps  

I plan to extend this project by building an **interactive dashboard** (e.g., in Power BI or Tableau) to visualise prevalence, care processes, treatment targets, and equity more dynamically. This would demonstrate how insights from the analysis can be delivered to stakeholders in a practical, user-friendly format.  

---

## ğŸ”— More About Me  

Check out more of my work on my [GitHub profile](https://github.com/yourusername) or connect with me on [LinkedIn](https://linkedin.com/in/yourusername).  

Thank you for visiting!  
